ContraVir Appoints Industry Veteran William Hornung As Its Chief Financial Officer
7/8/2014 10:56:01 AM
ContraVir Pharmaceuticals, Inc. (OTCBB:CTRV), an emerging biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that William Hornung has joined the Company as its Chief Financial Officer. Mr. Hornung has over 22 years of finance and operations leadership experience in the biopharmaceutical industry with companies such as PTC Therapeutics (NASDAQ:PTCT), Elan Pharmaceuticals, and The Liposome Company.
Help employers find you! Check out all the jobs and post your resume.
comments powered by